دورية أكاديمية
Bone quality in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a one-year prospective natural history study.
| العنوان: | Bone quality in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a one-year prospective natural history study. |
|---|---|
| المؤلفون: | Bouman, K., Dittrich, A.T.M., Groothuis, J.T., Engelen, B.G.M. van, Zweers-van Essen, H.E., Baaij-Daalmeyer, A. de, Janssen, M.C.H., Erasmus, C.E., Draaisma, J.M.T., Voermans, N.C. |
| المصدر: | Neuromuscular Disorders, 34, pp. 105-113 |
| سنة النشر: | 2024 |
| المجموعة: | Radboud University: DSpace |
| مصطلحات موضوعية: | All institutes and research themes of the Radboud University Medical Center, Radboudumc 0: Other Research DCMN: Donders Center for Medical Neuroscience, Radboudumc 18: Healthcare improvement science Paediatrics, Radboudumc 3: Disorders of movement DCMN: Donders Center for Medical Neuroscience, Radboudumc 6: Metabolic Disorders Gastroenterology, Radboudumc 6: Metabolic Disorders Internal Medicine, Radboudumc 6: Metabolic Disorders Paediatrics, Radboudumc 9: Rare cancers Paediatrics |
| الوصف: | Contains fulltext : 302682.pdf (Publisher’s version ) (Open Access) ; Fragility fractures are frequently reported in neuromuscular diseases and negatively influence functional prognosis, quality of life and survival. In LAMA2-related muscular dystrophy (LAMA2-MD) and SELENON(SEPN1)-related congenital myopathy (SELENON-RM) cross-sectional and prospective natural history studies on bone quality and fragility long bone fractures (LBFs) are lacking. We therefore aim to systematically assess bone quality and provide recommendations for clinical care. We performed a one-year prospective natural history study in 21 LAMA2-MD and 10 SELENON-RM patients including a standardized fracture history and bone quality assessment through dual energy Xray absorptiometry scan (DEXA-scan) and/or bone health index (BHI). Ninety percent of the LAMA2-MD and SELENON-RM patients showed low bone quality. Eight (38%) LAMA2-MD and five (50%) SELENON-RM patients had a history of fragility LBFs. During the one-year follow-up period, one LAMA2-MD patient (female, 3 years) experienced a fragility LBF of the right humerus. We found no difference in bone mineral density between baseline and one-year follow-up. Based on general international guidelines for osteoporosis, we advise adequate vitamin D and calcium intake, and standardized clinical follow-up through a DEXA-scan or BHI in all LAMA2-MD and SELENON-RM patients. On indication, patients should be referred to the pediatrics or internal medicine for consideration of additional treatments. ; 01 januari 2024 |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | unknown |
| العلاقة: | https://repository.ubn.ru.nl//bitstream/handle/2066/302682/302682.pdfTest; https://repository.ubn.ru.nl/handle/2066/302682Test |
| DOI: | 10.1016/j.nmd.2023.11.008 |
| الإتاحة: | https://doi.org/10.1016/j.nmd.2023.11.008Test https://repository.ubn.ru.nl//bitstream/handle/2066/302682/302682.pdfTest https://repository.ubn.ru.nl/handle/2066/302682Test |
| رقم الانضمام: | edsbas.EBCC8F7A |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.nmd.2023.11.008 |
|---|